Tretinoin (0.03%, 0.045%, 0.06%, 0.08%) | Niacinamide 3%
Tretinoin (0.03%, 0.045%, 0.06%, 0.08%) | Niacinamide 3% is a dermatology-focused preparation for prescriber-directed skin protocols. Ingredient selection should reflect the patient's diagnosis, skin type, tolerability, pregnancy status, and treatment goal.
This compounded topical formulation combines tretinoin at variable concentrations with niacinamide (vitamin B3) at 3%. Tretinoin normalizes epidermal keratinocyte turnover, stimulates collagen, and reduces melanin—addressing acne, photoaging, and pigmentation disorders. Niacinamide complements tretinoin by inhibiting melanosome transfer from melanocytes to keratinocytes, providing anti-inflammatory benefits, and enhancing the skin barrier, which improves overall tolerability of the retinoid. Genesis Compounding prepares this as a prescription-only, patient-specific 503A compounded preparation and it is not FDA-approved as a compounded product.
| Active Ingredient | Pharmacologic Role |
|---|---|
| Tretinoin (0.03–0.08%) | Retinoic acid receptor agonist that accelerates keratinocyte turnover, stimulates procollagen synthesis, reduces melanin pigmentation, and normalizes follicular epithelial differentiation for acne, photoaging, and hyperpigmentation. |
| Niacinamide 3% | Vitamin B3 that inhibits melanosome transfer from melanocytes to keratinocytes, provides anti-inflammatory and anti-sebaceous effects, enhances ceramide and barrier lipid synthesis, and reduces retinoid-induced irritation. |
Applied topically to the face or affected area once nightly as directed by the prescriber. Apply a pea-sized amount to clean, dry skin, avoiding the eyes and mucous membranes. Allow to absorb before applying other products. Use broad-spectrum SPF 30+ sunscreen every morning without exception.
Apply once nightly. Prescribers typically initiate at the lowest indicated concentration (0.03%) and titrate upward based on 8–12-week response assessments.
- Adjust frequency (alternate nights at initiation) if significant retinoid dermatitis develops
- All dose and concentration decisions are made by the prescribing clinician
- Tretinoin: Activates RAR nuclear receptors (especially RAR-α) which form heterodimers with RXR, binding retinoic acid response elements (RAREs) in the genome. This drives increased epidermal cell turnover (clearing comedones and promoting epidermal renewal), upregulation of procollagen type I and III (repairing photodamage), MMP suppression, reduced tyrosinase activity, and melanin dispersal (depigmentation).
- Niacinamide: Acts downstream of melanin synthesis—it interrupts the vesicular transfer of melanosomes (melanin granule packages) from melanocytes to surrounding keratinocytes via inhibition of the melanosome transfer protein system. This reduces visible skin pigmentation without destroying melanocytes. Additionally, niacinamide upregulates ceramide and other stratum corneum lipid synthesis, strengthening the skin barrier and reducing TEWL (trans-epidermal water loss), which may reduce retinoid-induced dryness and irritation.
This formulation is used prescriber-directed for acne vulgaris, photoaging, melasma, post-inflammatory hyperpigmentation, and uneven skin tone. The niacinamide component offers additive depigmenting, anti-inflammatory (useful for acne and rosacea-prone skin), and barrier-strengthening effects, while reducing retinoid intolerance.
Monitoring considerations:
- Evaluate at 8–12 weeks for acne response, photoaging, or pigmentation improvement
- Monitor for retinoid dermatitis; adjust concentration or frequency as needed
- Counsel on mandatory daily sun protection
- Confirm negative pregnancy test in reproductive-age women; avoid in first trimester
Contraindications:
- Hypersensitivity to tretinoin, retinoids, or niacinamide
- Pregnancy (particularly first trimester)
- Sunburned or acutely inflamed skin
Warnings & Precautions:
- Photosensitivity: mandatory daily sunscreen
- Retinoid dermatitis: erythema, peeling, scaling are expected initially
- Avoid concurrent abrasive or drying skin-care ingredients
- Niacinamide is generally well-tolerated; high concentrations (>5%) may rarely cause flushing
Drug Interactions:
- Simultaneous benzoyl peroxide may inactivate tretinoin; use at different times
- Alcohol-based or abrasive products increase retinoid dermatitis
Common Side Effects: Erythema, peeling, stinging, and photosensitivity (tretinoin). Niacinamide is well tolerated at 3%.
Store at room temperature (15–25°C) in opaque packaging, protected from light. Do not freeze. Use within the beyond-use date specified by Genesis Compounding.
What does niacinamide add to a tretinoin cream?
Niacinamide provides complementary depigmenting effects (by blocking melanosome transfer), reduces acne-related redness, strengthens the skin barrier, and may reduce the dryness and irritation caused by tretinoin—potentially improving adherence.
How should I apply this combination?
Apply a pea-sized amount to clean, dry skin at bedtime. Avoid eye and mouth areas. Allow to absorb before applying a moisturizer if needed. Always apply SPF 30+ sunscreen the following morning.
Is this FDA-approved?
This is a 503A compounded preparation by Genesis Compounding. Tretinoin alone is FDA-approved topically; this specific combination is a compounded, patient-specific preparation and is not independently FDA-approved.
How long before I see improvement?
Acne improvements may begin within 4–8 weeks. Photoaging and pigmentation improvements typically require 12–24 weeks of consistent nightly use.
Can I use this if I have sensitive or rosacea-prone skin?
Discuss with your prescriber. Starting at the lowest concentration (0.03%) with a gradual titration schedule, combined with the anti-inflammatory effects of niacinamide, may make this formulation tolerable for sensitive skin types.
Clinical References
Authoritative sources reviewed in preparing this clinical summary. Provided for prescriber reference; not a substitute for the prescriber’s clinical judgment.